News Flash Home
The original item was published from 5/20/2020 1:16:00 PM to 5/28/2020 8:09:56 AM.

News Flash

Draper News

Posted on: May 15, 2020

[ARCHIVED] COVID-19 Antibody Testing (SOLD OUT)

testing square

Note: We are SOLD OUT! Future dates may be scheduled soon. Check back to see if more dates are added. Draper City announced today that residents have an opportunity to test for COVID-19 antibodies starting Wednesday, May 20. If residents think they have been exposed, or just want to know if they have had COVID-19, they are invited to come and take a test. Draper, along with the cities of Bluffdale, Riverton and Vineyard, are sponsoring the privately administered COVID-19 screening program.

Any residents interested in being tested may sign up for an appointment online at rapidscreen.as.me on a first-come, first-served basis. The screening costs $69.99 (may be reimbursable by health insurance plans, check with your provider), payable by credit or debit card at the time of booking. Appointments are booked in 30-minute increments throughout each day and conducted in a drive-thru setting. Results are available within 15-20 minutes. The testing schedule is as follows:

  • Wednesday, May 20 – Draper (Galena Hills Park)
  • Thursday, May 21 – Riverton
  • Tuesday, May 26 – Draper (Galena Hills Park)
  • Thursday, May 28 – Bluffdale
  • Friday, May 29 – Vineyard

Testing will be conducted by Utah-based RapidScreen Solutions, LLC (RSS) using testing kits manufactured in the United States from New York-based Chembio. The test is a lateral flow blood test that has Emergency Use Authorization (EUA) from the FDA. Using a finger-stick test, a small (drop) blood sample is taken from a finger and placed on a test strip to detect two different antibodies in the subject’s blood: IgM and IgG. Positive results indicate the likelihood of a current or past COVID-19 infection.

In addition, RSS will randomly administer a saliva-based DNA test to some test subjects. Draper-based Spectrum Solutions manufactures the saliva tests that detect active COVID-19 infection, rather than detecting antibodies. Any person who tests positive for antibodies will also receive the saliva test to confirm active COVID-19 infection.

The testing will be conducted in full compliance with FDA and CLIA requirements. The test results will not be diagnostic, but are designed to provide valuable data about the COVID-19 infection rate. Residents can expect the following to occur when participating in the testing process:

1. The individual will register for an appointment time and pay for the test via rapidscreen.as.me.

2. The individual will report to the test site at their appointed time, remain in their vehicle and follow the traffic directions to a health professional who will administer the test. There will be several lines for vehicles to cue into for testing.

3. The individual will present their hand out of their vehicle window for a quick finger prick to have the test administered.

4. The individual will pull their vehicle into the designated waiting area and await their test results.

Mayors from the participating communities released this joint statement about the project:

“We believe a central component to beating COVID-19 is to test our residents. We need to know our true infection rate so we can take actions to limit spread, conduct contact tracing and make future data-driven public policy decisions. We invite all our residents to consider being tested for COVID-19 antibodies as we continue to battle this virus.”

Facebook Twitter Email